8-K Announcements
6Material company update
Apr 21, 2026·SEC
Material company update
Mar 11, 2026·SEC
Material company update
Feb 3, 2026·SEC
Chubb Limited(CB)Earnings, Financials & Key Ratios
CB•NYSE•Insurance & Managed Care
$322.57
$125.88B mkt cap·12.5× P/E·Price updated May 6, 2026
SectorFinancial ServicesIndustryProperty & Casualty InsuranceSub-IndustryCommercial lines and surety insurers
AboutChubb Limited provides insurance and reinsurance products worldwide. The company's North America Commercial P&C Insurance segment offers commercial property, casualty, workers' compensation, package policies, risk management, financial lines, marine, construction, environmental, medical, cyber risk, surety, and excess casualty; and group accident and health insurance to large, middle market, and small commercial businesses. Its North America Personal P&C Insurance segment provides affluent and high net worth individuals and families with homeowners, automobile and collector cars, valuable articles, personal and excess liability, travel insurance, and recreational marine insurance and services. The company's North America Agricultural Insurance segment offers multiple peril crop and crop-hail insurance; and coverage for farm and ranch property, and commercial agriculture products. Its Overseas General Insurance segment provides coverage for traditional commercial property and casualty; specialty categories, such as financial lines, marine, energy, aviation, political risk, and construction risk; and group accident and health, and traditional and specialty personal lines for corporations, middle markets, and small customers through retail brokers, agents, and other channels. The company's Global Reinsurance segment offers traditional and specialty reinsurance under the Chubb Tempest Re brand to property and casualty companies. Its Life Insurance segment provides protection and savings products comprising whole life, endowment plans, individual term life, group term life, medical and health, personal accident, credit life, universal life, and unit linked contracts. The company markets its products primarily through insurance and reinsurance brokers. The company was formerly known as ACE Limited and changed its name to Chubb Limited in January 2016. Chubb Limited was incorporated in 1985 and is headquartered in Zurich, Switzerland.Show more
- Revenue$59.78B+6.5%
- Combined Ratio78.18%-1.8%
- Net Income$10.31B+11.2%
- Return on Equity13.92%-0.9%
- Medical Cost Ratio70.55%-0.9%
- Operating Margin21.82%+7.0%
- Net Margin17.25%+4.4%
- ROA4.17%+7.3%
- Equity / Assets32.19%+16.0%
- Book Value per Share201.21+21.2%
- Tangible BV/Share134.50+41.3%
- Debt/Equity0.28+24.4%
CB Key Insights
Chubb Limited (CB) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Profitable underwriting: 78.2% combined ratio
- ✓Strong 5Y profit CAGR of 23.9%
- ✓Strong Piotroski F-Score: 7/9
- ✓Share count reduced 3.7% through buybacks
✗Weaknesses
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
CB Price & Volume
Chubb Limited (CB) stock price & volume — 10-year historical chart
Loading chart...
CB Growth Metrics
Chubb Limited (CB) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years12.16%
5 Years10.64%
3 Years11.63%
TTM6.51%
Profit CAGR
10 Years13.79%
5 Years23.89%
3 Years25.26%
TTM11.2%
EPS CAGR
10 Years11.56%
5 Years26.99%
3 Years27.58%
TTM13.25%
Return on Capital
10 Years4.07%
5 Years4.55%
3 Years4.84%
Last Year5.28%
CB Recent Earnings
Chubb Limited (CB) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 12/12 qtrs (100%)●Beat Revenue 12/12 qtrs (100%)
Q2 2026Latest
Apr 21, 2026EPS
$6.82
Est $6.60
+3.3%
Revenue
$14.0B
Est $13.6B
+3.3%
Q1 2026
Feb 3, 2026EPS
$7.52
Est $6.77
+11.1%
Revenue
$13.1B
Est $12.9B
+1.5%
Q4 2025
Oct 21, 2025EPS
$7.49
Est $6.17
+21.4%
Revenue
$16.1B
Est $13.0B
+24.3%
Q3 2025
Jul 22, 2025EPS
$6.14
Est $5.98
+2.7%
Revenue
$14.9B
Est $14.2B
+5.2%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 21, 2026 | $6.82vs $6.60+3.3% | $14.0Bvs $13.6B+3.3% |
| Q1 2026 | Feb 3, 2026 | $7.52vs $6.77+11.1% | $13.1Bvs $12.9B+1.5% |
| Q4 2025 | Oct 21, 2025 | $7.49vs $6.17+21.4% | $16.1Bvs $13.0B+24.3% |
| Q3 2025 | Jul 22, 2025 | $6.14vs $5.98+2.7% | $14.9Bvs $14.2B+5.2% |
Based on last 12 quarters of dataView full earnings history →
CB Peer Comparison
Chubb Limited (CB) competitors in Commercial lines and surety insurers — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 AIG | 42.1B | 78.47 | 14.45 | -1.82% | 11.86% | 7.7% | 7.87% | 0.22 |
 TRV | 65.17B | 301.39 | 10.99 | 5.17% | 12.88% | 19.12% | 0.28 | |
 HIG | 36.89B | 134.15 | 10.07 | 7.1% | 14.13% | 22.01% | 15.59% | 0.23 |
 ALL | 56.25B | 218.51 | 5.72 | 4.64% | 18.09% | 42.74% | 17.57% | 0.24 |
 CNA | 12.05B | 44.53 | 9.49 | 5.1% | 8.69% | 11.65% | 19.96% | 0.27 |
 MKL | 22.08B | 1764.81 | 10.43 | -0.96% | 10.7% | 9.56% | 11.57% | 0.23 |
 WRB | 24.9B | 66.49 | 14.94 | 7.82% | 12.1% | 18.86% | 13.93% | 0.29 |
 RNR | 13.03B | 302.04 | 5.33 | 9.45% | 26.93% | 16.59% | 28.33% | 0.12 |
Compare CB vs Peers
Chubb Limited (CB) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
CB Income Statement
Chubb Limited (CB) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 32.34B | 32.68B | 34.23B | 36.05B | 40.77B | 42.98B | 50.13B | 56.15B | 59.78B |
| Revenue Growth % | 2.73% | 1.05% | 4.75% | 5.32% | 13.09% | 5.41% | 16.66% | 12% | 6.47% |
| Medical Costs & Claims | 24.91B | 24.57B | 25.62B | 29.04B | 29.44B | 32.15B | 36.29B | 39.98B | 42.18B |
| Medical Cost Ratio % | 77.03% | 75.18% | 74.86% | 80.55% | 72.2% | 74.8% | 72.4% | 71.2% | 70.55% |
| Gross Profit | 7.43B▲ 0% | 8.11B▲ 9.2% | 8.61B▲ 6.1% | 7.01B▼ 18.5% | 11.33B▲ 61.6% | 10.83B▼ 4.4% | 13.84B▲ 27.8% | 16.17B▲ 16.9% | 17.61B▲ 8.9% |
| Gross Margin % | 22.97% | 24.82% | 25.14% | 19.45% | 27.8% | 25.2% | 27.6% | 28.8% | 29.45% |
| Gross Profit Growth % | -16.86% | 9.17% | 6.13% | -18.54% | 61.65% | -4.44% | 27.78% | 16.86% | 8.86% |
| Operating Expenses | 3.71B | 3.45B | 3.36B | 2.85B | 1.54B | 4.34B | 4.31B | 4.72B | 4.56B |
| OpEx / Revenue % | 11.46% | 10.57% | 9.81% | 7.9% | 3.77% | 10.11% | 8.6% | 8.4% | 7.63% |
| Depreciation & Amortization | 260M | 339M | 305M | 290M | 287M | 285M | 310M | 323M | 301M |
| Combined Ratio % | 88.49% | 85.75% | 84.67% | 88.46% | 75.98% | 84.91% | 81% | 79.6% | 78.18% |
| Operating Income | 3.72B▲ 0% | 4.66B▲ 25.1% | 5.25B▲ 12.7% | 4.16B▼ 20.7% | 9.79B▲ 135.3% | 6.49B▼ 33.8% | 9.53B▲ 46.9% | 11.46B▲ 20.2% | 13.04B▲ 13.9% |
| Operating Margin % | 11.51% | 14.25% | 15.33% | 11.54% | 24.02% | 15.09% | 19% | 20.4% | 21.82% |
| Operating Income Growth % | -24.81% | 25.12% | 12.71% | -20.71% | 135.32% | -33.79% | 46.89% | 20.25% | 13.87% |
| EBITDA | 3.98B | 5B | 5.55B | 4.45B | 10.08B | 6.77B | 9.84B | 11.78B | 13.35B |
| EBITDA Margin % | 12.31% | 15.29% | 16.23% | 12.35% | 24.73% | 15.75% | 19.62% | 20.98% | 22.32% |
| Interest Expense | 607M | 641M | 552M | 516M | 492M | 570M | 672M | 741M | 764M |
| Non-Operating Income | -607M | -641M | -552M | -516M | -492M | -570M | -672M | -741M | -764M |
| Pretax Income | 3.72B▲ 0% | 4.66B▲ 25.1% | 5.25B▲ 12.7% | 4.16B▼ 20.7% | 9.79B▲ 135.3% | 6.49B▼ 33.8% | 9.53B▲ 46.9% | 11.46B▲ 20.2% | 13.04B▲ 13.9% |
| Pretax Margin % | 11.51% | 14.25% | 15.33% | 11.54% | 24.02% | 15.09% | 19% | 20.4% | 21.82% |
| Income Tax | -139M | 695M | 795M | 629M | 1.27B | 1.24B | 511M | 1.81B | 2.42B |
| Effective Tax Rate % | -3.73% | 14.92% | 15.15% | 15.11% | 12.96% | 19.11% | 5.36% | 15.84% | 18.57% |
| Net Income | 3.86B▲ 0% | 3.96B▲ 2.6% | 4.45B▲ 12.4% | 3.53B▼ 20.7% | 8.53B▲ 141.3% | 5.25B▼ 38.5% | 9.03B▲ 72.1% | 9.27B▲ 2.7% | 10.31B▲ 11.2% |
| Net Margin % | 11.94% | 12.12% | 13.01% | 9.8% | 20.91% | 12.21% | 18.01% | 16.51% | 17.25% |
| Net Income Growth % | -6.63% | 2.62% | 12.42% | -20.68% | 141.3% | -38.46% | 72.09% | 2.7% | 11.2% |
| EPS (Diluted) | 8.19▲ 0% | 8.49▲ 3.7% | 9.71▲ 14.4% | 7.79▼ 19.8% | 19.27▲ 147.4% | 12.39▼ 35.7% | 21.80▲ 75.9% | 22.70▲ 4.1% | 25.73▲ 13.3% |
| EPS Growth % | -7.67% | 3.66% | 14.37% | -19.77% | 147.37% | -35.7% | 75.95% | 4.13% | 13.35% |
| EPS (Basic) | 8.26 | 8.55 | 9.77 | 7.82 | 19.38 | 12.50 | 21.97 | 22.94 | 25.91 |
| Diluted Shares Outstanding | 471.2M | 466.8M | 458.91M | 453.44M | 443.2M | 423.53M | 414.2M | 411.91M | 396.5M |
CB Balance Sheet
Chubb Limited (CB) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 167.02B | 167.77B | 176.94B | 190.77B | 200.05B | 199.02B | 230.68B | 246.55B | 247.83B |
| Asset Growth % | 4.53% | 0.45% | 5.47% | 7.82% | 4.86% | -0.52% | 15.91% | 6.88% | 0.52% |
| Total Investment Assets | 662M | 678M | 110.57B | 205.77B | 207.41B | 135.98B | 162.55B | 178.95B | 175.65B |
| Long-Term Investments | 662M | 678M | 103.17B | 110.72B | 111.15B | 112.21B | 131.21B | 142.05B | 175.65B |
| Short-Term Investments | 0 | 0 | 89.78B | 95.04B | 96.25B | 23.77B | 31.34B | 36.9B | 0 |
| Total Current Assets | 728M | 1.25B | 0 | 0 | 0 | 0 | 0 | 0 | 18.41B |
| Cash & Equivalents | 728M | 1.25B | 1.54B | 1.75B | 1.66B | 2.01B | 2.45B | 2.29B | 2.47B |
| Receivables | 24.55B | 26.27B | 25.73B | 26.28B | 28.9B | 31.09B | 33.61B | 34.49B | 15.94B |
| Other Current Assets | -107.05B | -107.76B | -119.7B | -125.84B | -129.84B | -60.02B | -70.62B | -77.06B | 0 |
| Goodwill & Intangibles | 27.12B | 26.64B | 21.66B | 21.47B | 20.9B | 25.37B | 30.14B | 29.18B | 26.45B |
| Goodwill | 15.54B | 15.27B | 15.3B | 15.4B | 15.21B | 16.23B | 19.69B | 19.58B | 20.21B |
| Intangible Assets | 11.58B | 11.37B | 6.37B | 6.07B | 5.69B | 9.14B | 10.45B | 9.6B | 6.24B |
| PP&E (Net) | 1.3B | 1.7B | 0 | 0 | 0 | 0 | 0 | 0 | 4.53B |
| Other Assets | 135.45B | 135.51B | -124.84B | -132.2B | -132.06B | -137.58B | -161.34B | -171.23B | 21.48B |
| Total Liabilities | 99.31B | 100.16B | 121.61B | 131.33B | 140.34B | 148.5B | 166.99B | 178.15B | 168.05B |
| Total Debt | 12.57B | 14.32B | 14.86B | 14.95B | 16.17B | 14.88B | 14.49B | 15.29B | 22.19B |
| Net Debt | 11.84B | 11.35B | 13.32B | 13.2B | 14.51B | 12.87B | 12.05B | 13B | 19.72B |
| Long-Term Debt | 11.86B | 12.39B | 13.56B | 14.95B | 15.17B | 14.4B | 13.04B | 14.49B | 16.15B |
| Short-Term Debt | 2.42B | 1.93B | 1.3B | 0 | 999M | 475M | 1.46B | 800M | 5.03B |
| Total Current Liabilities | 57.72B | 56.81B | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payable | 5.87B | 6.44B | 6.18B | 6.71B | 7.24B | 7.78B | 8.3B | 8.12B | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 49.43B | 48.44B | -7.48B | -6.71B | -8.24B | -8.26B | -9.76B | -8.92B | -5.03B |
| Deferred Taxes | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Liabilities | 27.27B | 28.67B | -14.36B | -15.84B | -15.56B | -14.78B | -14.59B | -16.07B | 149.16B |
| Total Equity | 51.17B▲ 0% | 50.31B▼ 1.7% | 55.33B▲ 10.0% | 59.44B▲ 7.4% | 59.71B▲ 0.5% | 50.52B▼ 15.4% | 63.69B▲ 26.1% | 68.39B▲ 7.4% | 79.78B▲ 16.6% |
| Equity Growth % | 6% | -1.68% | 9.98% | 7.43% | 0.46% | -15.4% | 26.07% | 7.38% | 16.65% |
| Shareholders Equity | 51.17B | 50.31B | 55.33B | 59.44B | 59.71B | 50.52B | 59.51B | 64.02B | 73.76B |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 4.18B | 4.37B | 6.02B |
| Retained Earnings | 27.47B | 31.7B | 36.14B | 39.34B | 47.37B | 48.3B | 54.81B | 61.56B | 69.95B |
| Common Stock | 11.12B | 11.12B | 11.12B | 11.06B | 10.98B | 10.35B | 241M | 235M | 231M |
| Accumulated OCI | 543M | -2.45B | 619M | 2.87B | 350M | -10.19B | -6.81B | -8.64B | -4.97B |
| Return on Equity (ROE) | 7.76% | 7.81% | 8.43% | 6.16% | 14.31% | 9.52% | 15.81% | 14.04% | 13.92% |
| Return on Assets (ROA) | 2.36% | 2.37% | 2.58% | 1.92% | 4.36% | 2.63% | 4.2% | 3.89% | 4.17% |
| Equity / Assets | 30.64% | 29.99% | 31.27% | 31.16% | 29.85% | 25.38% | 27.61% | 27.74% | 32.19% |
| Debt / Equity | 0.25x | 0.28x | 0.27x | 0.25x | 0.27x | 0.29x | 0.23x | 0.22x | 0.28x |
| Book Value per Share | 108.60 | 107.78 | 120.57 | 131.09 | 134.73 | 119.28 | 153.77 | 166.04 | 201.21 |
| Tangible BV per Share | 51.04 | 50.70 | 73.36 | 83.73 | 87.57 | 59.38 | 81.01 | 95.20 | 134.50 |
CB Cash Flow Statement
Chubb Limited (CB) cash flow — operating, investing & free cash flow history
| Line item | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | Dec'25 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 4.5B | 5.48B | 6.34B | 9.79B | 11.15B | 11.26B | 12.63B | 16.18B | 14.54B |
| Operating CF Growth % | -14.91% | 21.7% | 15.73% | 54.29% | 13.96% | 0.96% | 12.2% | 28.1% | -10.17% |
| Operating CF / Revenue % | 13.92% | 16.77% | 18.53% | 27.14% | 27.35% | 26.2% | 25.2% | 28.82% | 24.32% |
| Net Income | 3.86B | 3.96B | 4.45B | 3.53B | 8.53B | 5.25B | 9.02B | 9.64B | 10.31B |
| Depreciation & Amortization | 260M | 339M | 305M | 290M | 287M | 285M | 310M | 323M | 301M |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | -527M | 16M | -97M | -333M | -84M | 318M | -1.12B | 96M | 0 |
| Other Non-Cash Items | 710M | 893M | 963M | 605M | 101M | 1.98B | 2.17B | 341M | -186M |
| Working Capital Changes | 199M | 270M | 717M | 5.69B | 2.32B | 3.43B | 2.26B | 5.78B | 4.11B |
| Cash from Investing | -2.42B | -2.94B | -5.91B | -7.52B | -6.66B | -5.65B | -7.65B | -13.92B | -12.98B |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions | -648M | -1.34B | -1.92B | -3.55B | -3.65B | -7.82B | -2.08B | -1.58B | -289M |
| Purchase of Investments | -27.07B | -25.38B | -28.43B | -33.11B | -32.2B | -30.89B | -30.43B | -38.95B | -37.14B |
| Sale/Maturity of Investments | 24.75B | 23.34B | 23.71B | 28.7B | 28.11B | 32.6B | 24.58B | 26.62B | 28.18B |
| Other Investing | 554M | 447M | 733M | 437M | 1.08B | 457M | 275M | -15M | -3.73B |
| Cash from Financing | -2.32B | -1.99B | -151M | -2.08B | -4.41B | -5.14B | -4.49B | -2.18B | -1.85B |
| Dividends Paid | -1.31B | -1.34B | -1.35B | -1.39B | -1.4B | -1.38B | -1.39B | -1.44B | -1.5B |
| Share Repurchases | -801M | -1.04B | -1.53B | -523M | -4.86B | -2.89B | -2.41B | -1.8B | -3.69B |
| Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 327M |
| Debt Issuance (Net) | -1000K | 1000K | 1000K | -1000K | 1000K | -1000K | -1000K | 1000K | 1000K |
| Other Financing | 291M | 220M | 415M | 142M | 275M | 127M | -209M | 85M | 794M |
| Net Change in Cash | -237M▲ 0% | 489M▲ 306.3% | 306M▼ 37.4% | 190M▼ 37.9% | -25M▼ 113.2% | 316M▲ 1364.0% | 494M▲ 56.3% | -72M▼ 114.6% | -79M▼ 9.7% |
| Exchange Rate Effect | 1M | -65M | 20M | 8M | -106M | -146M | -1M | -150M | 215M |
| Cash at Beginning | 1.09B | 851M | 1.34B | 1.65B | 1.84B | 1.81B | 2.13B | 2.62B | 2.55B |
| Cash at End | 851M | 1.34B | 1.65B | 1.84B | 1.81B | 2.13B | 2.62B | 2.55B | 2.47B |
| Free Cash Flow | 4.5B▲ 0% | 5.48B▲ 21.7% | 6.34B▲ 15.7% | 9.79B▲ 54.3% | 11.15B▲ 14.0% | 11.26B▲ 1.0% | 12.63B▲ 12.2% | 16.18B▲ 28.1% | 14.54B▼ 10.2% |
| FCF Growth % | -14.91% | 21.7% | 15.73% | 54.29% | 13.96% | 0.96% | 12.2% | 28.1% | -10.17% |
| FCF Margin % | 13.92% | 16.77% | 18.53% | 27.14% | 27.35% | 26.2% | 25.2% | 28.82% | 24.32% |
| FCF per Share | 9.56 | 11.74 | 13.82 | 21.58 | 25.16 | 26.58 | 30.5 | 39.29 | 36.66 |
CB Key Ratios
Chubb Limited (CB) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Combined Ratio | 84.28% | 88.49% | 85.75% | 84.67% | 88.46% | 75.98% | 84.91% | 81% | 79.6% | 78.18% |
| Medical Cost Ratio | 71.61% | 77.03% | 75.18% | 74.86% | 80.55% | 72.2% | 74.8% | 72.4% | 71.2% | 70.55% |
| Return on Equity (ROE) | 10.68% | 7.76% | 7.81% | 8.43% | 6.16% | 14.31% | 9.52% | 15.81% | 14.04% | 13.92% |
| Return on Assets (ROA) | 3.16% | 2.36% | 2.37% | 2.58% | 1.92% | 4.36% | 2.63% | 4.2% | 3.89% | 4.17% |
| Equity / Assets | 30.21% | 30.64% | 29.99% | 31.27% | 31.16% | 29.85% | 25.38% | 27.61% | 27.74% | 32.19% |
| Book Value / Share | 103.61 | 108.6 | 107.78 | 120.57 | 131.09 | 134.73 | 119.28 | 153.77 | 166.04 | 201.21 |
| Debt / Equity | 0.31x | 0.25x | 0.28x | 0.27x | 0.25x | 0.27x | 0.29x | 0.23x | 0.22x | 0.28x |
| Revenue Growth | 65.96% | 2.73% | 1.05% | 4.75% | 5.32% | 13.09% | 5.41% | 16.66% | 12% | 6.47% |
CB SEC Filings & Documents
Chubb Limited (CB) SEC filings — annual & quarterly reports (10-K, 10-Q)
CB Frequently Asked Questions
Chubb Limited (CB) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Chubb Limited (CB) grew revenue by 6.5% over the past year. This is steady growth.
Yes, Chubb Limited (CB) is profitable, generating $10.31B in net income for fiscal year 2025 (17.2% net margin).
Dividend & Returns
Yes, Chubb Limited (CB) pays a dividend with a yield of 1.18%. This makes it attractive for income-focused investors.
Chubb Limited (CB) has a return on equity (ROE) of 13.9%. This is reasonable for most industries.
Industry Metrics
Chubb Limited (CB) has a combined ratio of 78.2%. A ratio below 100% indicates underwriting profitability.
Explore More CB
Chubb Limited (CB) financial analysis — history, returns, DCA and operating performance tools
Full CB Stock Analysis
Analyst verdict, bull/bear case, risk factors and peer comparison
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates